PVCT
Provectus Biopharmaceuticals Inc.

1,941
Mkt Cap
$21.39M
Volume
161,552.00
52W High
$0.113
52W Low
$0.038
PE Ratio
-3.22
PVCT Fundamentals
Price
$0.049
Prev Close
$0.0509
Open
$0.0509
50D MA
$0.0537
Beta
0.24
Avg. Volume
465,911.63
EPS (Annual)
-$0.0113
P/B
-3.47
Rev/Employee
$102,856.67
$53.12
Loading...
Loading...

About

Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treat several life-threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The company was founded by Eric A. Wachter on January 17, 2002 and is headquartered in Knoxville, TN.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
6

Frequently Asked Questions

What is Market Cap of Provectus Biopharmaceuticals Inc?
What is the 52-week high for Provectus Biopharmaceuticals Inc?
What is the 52-week low for Provectus Biopharmaceuticals Inc?
What is Provectus Biopharmaceuticals Inc stock price today?
What was Provectus Biopharmaceuticals Inc stock price yesterday?
What is the PE ratio of Provectus Biopharmaceuticals Inc?
What is the Price-to-Book ratio of Provectus Biopharmaceuticals Inc?
What is the 50-day moving average of Provectus Biopharmaceuticals Inc?
How many employees does Provectus Biopharmaceuticals Inc have?

Latest PVCT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.